So far no one has come with any facts, just wild speculations based on nothing. I am sure something will come up in the news tonight.
Just saw the latest amendment to the bill. It allows for counties to decide if they want to require a prescription for non-exempt pseudoephedrine products through an ordinance, so at least that is better than nothing.
The only chance for SB 6 to be useful is for the house to put back the prescription requirements back on the second reading tomorrow, but I really doubt that will happen. SB 6 is not dead and will probably pass, but not with the prescription only requirement we wanted. The lobbyists are flexing their muscles are it seems like they can't be stopped.
Without the prescription only clause for sudafed, this bill is not a big deal for ACUR, regardless of nexafed's exemption. The idea was that sudafed would be out of the competition, but now, you can get up to 10 boxes of sudafed per year, which is way more than what the average person needs.
The press does not have very good things to say about zohydro, plus it seems that the FDA approval process was very shady
I don't think that big pharma is interested yet in Acura, hopefully they will be soon, but there is no concrete evidence, just wishful thinking.
I don't understand where this is coming from, where is the supporting information? also, if this were true, the stock price right now would be a lot higher, so I am calling BS.